Evidence map›Paper›PMID 34273410›Full record

ArticleJournal of molecular and cellular cardiology2021

Early adaptive chromatin remodeling events precede pathologic phenotypes and are reinforced in the failing heart.

Douglas J Chapski, Maximilian Cabaj, Marco Morselli, Rosibel J Mason, Elizabeth Soehalim, Shuxun Ren, Matteo Pellegrini, Yibin Wang, Thomas M Vondriska, Manuel Rosa-Garrido

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Review
  3. Cardiac epigenome in heart development and disease.Nature reviews. Cardiology · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Epigenetics in Heart Failure.International journal of molecular sciences · 2024
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. How Chromatin Stiffens Fibroblasts.Current opinion in physiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Douglas J ChapskiDepartment of Anesthesiology & Perioperative Medicine, David Geffen School of Medicine at UCLA, United States of America.
Maximilian CabajDepartment of Anesthesiology & Perioperative Medicine, David Geffen School of Medicine at UCLA, United States of America.
Marco MorselliDepartment of Molecular, Cellular & Developmental Biology, David Geffen School of Medicine at UCLA, United States of America.
Rosibel J MasonDepartment of Anesthesiology & Perioperative Medicine, David Geffen School of Medicine at UCLA, United States of America.
Elizabeth SoehalimDepartment of Anesthesiology & Perioperative Medicine, David Geffen School of Medicine at UCLA, United States of America.
Shuxun RenDepartment of Anesthesiology & Perioperative Medicine, David Geffen School of Medicine at UCLA, United States of America.
Matteo PellegriniDepartment of Molecular, Cellular & Developmental Biology, David Geffen School of Medicine at UCLA, United States of America.
Yibin WangDepartment of Anesthesiology & Perioperative Medicine, David Geffen School of Medicine at UCLA, United States of America; Department of Medicine, David Geffen School of Medicine at UCLA, United States of America; Department of Physiology(,) David Geffen School of Medicine at UCLA, United States of America.
Thomas M VondriskaDepartment of Anesthesiology & Perioperative Medicine, David Geffen School of Medicine at UCLA, United States of America; Department of Medicine, David Geffen School of Medicine at UCLA, United States of America; Department of Physiology(,) David Geffen School of Medicine at UCLA, United States of America.
Manuel Rosa-GarridoDepartment of Anesthesiology & Perioperative Medicine, David Geffen School of Medicine at UCLA, United States of America. Electronic address: mrgarrido@mednet.ucla.edu.
University of California, Los Angeles · US

Funding

Dynamics of Cardiac Nuclei in Heart DiseaseR01HL105699 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VONDRISKA, THOMAS M. · 2011 to 2025
$5.0M
Small molecule therapies targeting chromatin architecture in heart failureR01HL150225 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MCKINSEY, TIMOTHY, VONDRISKA, THOMAS M. · 2020 to 2023
$2.9M
Epigenomic Mechanisms of Heart FailureR01HL129639 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VONDRISKA, THOMAS M. · 2015 to 2018
$2.6M
Novel Mechanisms of LncRNA Mediated Epigenetic Regulation in Cardiac HypertrophyR01HL143058 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VONDRISKA, THOMAS M. · 2018 to 2021
$2.2M
Epigenomic basis of resilience to heart failureR21HL150667 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VONDRISKA, THOMAS M. · 2020 to 2021
$429k
NHLBI NIH HHS R01 HL105699NHLBI NIH HHS R01 HL129639NHLBI NIH HHS R01 HL143058NHLBI NIH HHS R01 HL150225NHLBI NIH HHS R21 HL150667
6 · The paper itself

Abstract

The temporal nature of chromatin structural changes underpinning pathologic transcription are poorly understood. We measured chromatin accessibility and DNA methylation to study the contribution of chromatin remodeling at different stages of cardiac hypertrophy and failure. ATAC-seq and reduced representation bisulfite sequencing were performed in cardiac myocytes after transverse aortic constriction (TAC) or depletion of the chromatin structural protein CTCF. Early compensation to pressure overload showed changes in chromatin accessibility and DNA methylation preferentially localized to intergenic and intronic regions. Most methylation and accessibility changes observed in enhancers and promoters at the late phase (3 weeks after TAC) were established at an earlier time point (3 days after TAC), before heart failure manifests. Enhancers were paired with genes based on chromatin conformation capture data: while enhancer accessibility generally correlated with changes in gene expression, this feature, nor DNA methylation, was alone sufficient to predict transcription of all enhancer interacting genes. Enrichment of transcription factors and active histone marks at these regions suggests that enhancer activity coordinates with other epigenetic factors to determine gene transcription. In support of this hypothesis, ChIP-qPCR demonstrated increased enhancer and promoter occupancy of GATA4 and NKX2.5 at Itga9 and Nppa, respectively, concomitant with increased transcription of these genes in the diseased heart. Lastly, we demonstrate that accessibility and DNA methylation are imperfect predictors of chromatin structure at the scale of A/B compartmentalization-rather, accessibility, DNA methylation, transcription factors and other histone marks work within these domains to determine gene expression. These studies establish that chromatin reorganization during early compensation after pathologic stimuli is maintained into the later decompensatory phases of heart failure. The findings reveal the rules for how local chromatin features govern gene expression in the context of global genomic structure and identify chromatin remodeling events for therapeutic targeting in disease.

Indexed as

Epigenesis, GeneticPhenotypeAnimalsCardiomegalyChromatinChromatin Assembly and DisassemblyDisease Models, AnimalDNA MethylationEnhancer Elements, GeneticGene ExpressionHeart FailureHistonesMiceMice, Inbred C57BLMice, KnockoutMyocytes, CardiacChromatinHistonesTranscription FactorsChromatin accessibilityCTCFDNA methylationEnhancersHeart failure

Identifiers

PMID34273410
PMCPMC9181638
OpenAlexW3186856472

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.